This review highlights the non-canonical roles of ACE in modulating hematopoiesis and immune cell function, which may explain some of the pleiotropic effects and immune-related consequences of ACE inhibitors.
Angiotensin-converting enzyme (ACE) is canonically known for its role in the renin-angiotensin system (RAS) where its conversion of angiotensin I (Ang I) to the bioactive peptide angiotensin II (Ang II) helps to regulate blood pressure, electrolyte, and volume homeostasis. Further studies on ACE have shown that its enzymatic activity is relatively non-specific and functions outside of the RAS axis. Of the multiple systems it has been implicated in, ACE has been found to play an important role in the development and modulation of hematopoiesis and the immune system, both through the RAS and independently of the RAS axis.
No takes yet. Share an insight, caveat, or question.
Leong et al. (2023) conducted a review in Immune system and hematopoiesis modulation by ACE. Angiotensin-converting enzyme (ACE) was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: